Stem cell factor plays a major role in the recruitment of eosinophils in allergic pleurisy in mice via the production of leukotriene B4

Journal of Immunology

Volumn 164, Issue 8, 2000, Pages 4271-4276

  Klein, Andre ^a   Talvani, Andre ^a   Cara, Denise C ^a   Gomes, Kenia L ^a   Lukacs, Nicholas W ^b   Teixeira, Mauro M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [3 (4 BIPHENYLYLMETHYL) 4 HYDROXYCHROMAN 7 YL]CYCLOPENTANECARBOXYLIC ACID; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; MESSENGER RNA; RECOMBINANT STEM CELL FACTOR; STEM CELL FACTOR;

ALLERGY; ANIMAL MODEL; ARTICLE; DOSE TIME EFFECT RELATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EXPERIMENTAL MODEL; GENE EXPRESSION; INFLAMMATION; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; PLEURISY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034655138     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.8.4271     Document Type: Article

References (34)

1. Djukanovic, R., J. W. Wilson, K. M. Britten, S. J. Wilson, A. F. Walls, W. R. Roche, P. H. Howarth, and S.T. Holgate. 1990. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am. Rev. Respir. Dis. 142: 863.
2. Schroder, J. M., N. Noso, M. Sticherling, and E. Christophers. 1996. Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammation. J. Leukocyte Biol. 59:1.
3. Giembycz, M. A., and M. A. Lindsay. 1999. Pharmacology of the eosinophil. Pharmacol. Rev. 51:213.
4. Cara, D. C., D. Negrao-Correa, and M. M. Teixeira. 2000. Mechanisms underlying eosinophil trafficking and their relevance in vivo. Histol. Histopathol. In press.
5. Teixeira, M. M., T. J. Williams, and P. G. Hellewell. 1995. Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo. Trends Pharmacol. Sci. 16:418.
6. Teixeira, M. M., T. N. C. Wells, N. W. Lukacs, A. E. E. Proudfoot, S. L. Kunkel, T. J. Williams, and P. G. Hellewell. 1997. Chemokine-induced eosinophil recruitment: evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J. Clin. Invest. 100:1656.
7. Humbles, A. A., D. M. Conroy, S. Marleau, S. M. Rankin, R. T. Palframan, A. E. Proudfoot, T. N. C. Wells, D. Li, P. K. Jeffery, D. A. Griffiths-Johnson, et al. 1997. Kinetics of eolaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J. Exp. Med. 186:601.
8. Gonzalo, J. A., G. Q. Jia, V. Aguirre, D. Friend, A. J. Coyle, N. A. Jenkins, G. S. Lin, H. Katz, A. Lichtman, N. Copeland, et al. 1996. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity 4:1.
9. Rothenberg, M. E. 1999. Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues. Am. J. Respir. Cell Mol. Biol. 21:291.
10. Teixeira, M. M., and P. G. Hellewell. 1994. Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea pig. Br. J. Pharmacol. 111:1205.
11. 4 antagonism in a primate model of asthma. J. Clin. Invest. 97:381.
12. 4 receptor antagonist CP-105696. J. Pharmacol. Exp. Ther. 273: 176.
13. Wasserman, S. I. 1989. Mast cell-mediated inflammation in asthma. Ann. Allergy 63:546.
14. 4 but no peptido-leukotriene. J. Immunol. 144:1880.
15. 4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. Am. Rev. Respir. Dis. 129:106.
16. 4 enhances IL-4-induced IgE production from normal human lymphocytes. Cell Immunol. 156:124.
17. 4-and C5a-induced eosinophil homotypic aggregation in vitro and recruitment in vivo. Blood 89:4566.
18. Macari, D. M. T., M. M. Teixeira, T. Ansari, P. K. Jeffery, and P. G. Hellewell. 1998. Priming and induction of eosinophil trafficking in guinea pig cutaneous inflammation by tumour necrosis factor α. Br. J. Pharmacol. 125:1228.
19. Yuan, Q., K. F. Austen, D. S. Friend, M. Heidtman, and J. A. Boyce. 1997. Human peripheral blood eosinophils express a functional c-kit receptor for stem cell factor that stimulates very late antigen 4 (VLA-4)-mediated cell adhesion to fibronectin and vascular cell adhesion molecule 1 (VCAN-1). J. Exp. Med. 186: 313.
20. Hogaboam, C., S. L. Kunkel, R. M. Strieter, D. D. Taub, P. Lincoln, T. J. Standiford, and N. W. Lukacs. 1998. Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions. J. Immunol. 160:6166.
21. Samet, J. M., M. B. Fasano, A. N. Fonteh, and F. H. Chilton. 1995. Selective induction of prostaglandin G/H synthase 1 by stem cell factor and dexamethasone in mast cells. J. Biol. Chem. 270:8044.
22. Das, A. M., R. J. Flower, P. G. Hellewell, M. M. Teixeira, and M. Perretti. 1997. A novel murine model of allergic inflammation to study the effect of dexamethasone on eosinophil recruitment. Br. J. Pharmacol. 121:97.
23. 4 receptors in vitro. Br. J. Pharmacol. 117:1127.
24. Talvani, A. C. S. Ribeiro, J. C. S. Aliberti, V. Michailowsky, P. V. A. Santos, S. M. F. Murta, A. J. Romanha, I. C. Almeida, J. Farber, J. Lannes-Vieira, et al. 2000. Kinetics of cytokine genes expression in experimental chagasic cardiomyopathy: a direct correlation between levels of tissue parasitism and chemokine mRNAs expression during infection with Trypanosyma cruzi. Microbes Infect. In press.
25. 2 generation in immature mouse mast cells. J. Biol. Chem. 270:3239.
26. 2 and 5-lipoxygenase. J. Exp. Med. 182:197.
27. Patella, V., I. Marino, E. Arbustini, B. Lamparter-Schummert, L. Verga. M. Adt, and G. Marone. 1998. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 97:971.
28. Columbo, M., E. M. Horowitz, L. M. Botana, D. W. MacGlashan, Jr., B. S. Bochner, S. Gillis, K. M. Zsebo, S. J. Galli, and L. M. Lichtenstein. 1992. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J. Immunol. 149:599.
29. 4 receptor expressed on eosinophils. J. Exp. Med. 188:1063.
30. Wershil, B. K., M. Tsai, E. N. Geissler, K. M. Zsebo, and S. J. Galli. 1992. The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo: evidence that signaling through the c-kit receptor can induce expression of cellular function. J. Exp. Med. 175:245.
31. Campbell, E., C. Hogaboam, P. Lincoln, and N. W. Lukacs. 1999. Stem cell factor-induced airway hyperreactivity in allergic and normal mice. Am. J. Pathol. 154:1259.
32. Lukacs, N. W., R. M. Strieter, P. M. Lincoln, E. Brownell, D. M. Pullen, H. J. Schock, S. W. Chensue, D. D. Taub, and S. L. Kunkel. 1996. Stem cell factor (c-kit ligand) influences eosinophil recruitment and histamine levels in allergic airway inflammation. J. Immunol. 156:3945.
33. Bischoff, S. C., and C. A. Dahinden. 1992. c-kit Ligand: a unique potentiator of mediator release by human lung mast cells. J. Exp. Med. 175:237.
34. Furuta, G. T., S. J. Ackerman, L. Lu., R. E. Williams, and B. K. Wershil. 1998. Stem cell factor influences mast cell mediator release in response to eosinophil-derived granule major basic protein. Blood 92:1055.